
Number of publications published per year by Forbes, William P.. (Source : PubMed)

Distribution of publications types for Forbes, William P.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)



Rifaximin treatment in hepatic encephalopathy.
N. Engl. J. Med.
2010;362;12


Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.
J. Pediatr. Gastroenterol. Nutr.
2009;49;5



Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Am. J. Gastroenterol.
2009;104;6



Clinical trial: sodium phosphate tablets are preferred and better tolerated by patients compared to polyethylene glycol solution plus bisacodyl tablets for bowel preparation.
Aliment. Pharmacol. Ther.
2007;26;10

The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
Pharmacotherapy
2007;27;10




A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing.
Am. J. Gastroenterol.
2007;102;10
[ See timeline ] [ See all publications ]
means that Forbes, William P. has 7 papers cited a least 7 times - methodology
University of California, San Francisco, San Francisco, California, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.